Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Capital Reinvestment Ratio
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Capital Reinvestment Ratio of 0.59x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.57 Million) in capital expenditures (CN¥9.26 Million). See Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Capital Reinvestment Ratio (2012–2023)
This chart tracks Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2012–2023)
Year-by-year Capital Reinvestment Ratio for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2012 to 2023. For live market cap and broader valuation context, see Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.28x | CN¥392.50 Million | CN¥109.97 Million | ▲ +258.8% |
| 2022 | 0.08x | CN¥4.01 Billion | CN¥313.38 Million | ▼ -15.0% |
| 2021 | 0.09x | CN¥1.13 Billion | CN¥103.57 Million | ▲ +16.9% |
| 2020 | 0.08x | CN¥359.68 Million | CN¥28.28 Million | ▼ -94.5% |
| 2019 | 1.42x | CN¥22.49 Million | CN¥31.94 Million | ▲ +60.6% |
| 2018 | 0.88x | CN¥53.67 Million | CN¥47.48 Million | ▼ -9.6% |
| 2017 | 0.98x | CN¥46.50 Million | CN¥45.52 Million | ▲ +43.1% |
| 2016 | 0.68x | CN¥58.86 Million | CN¥40.27 Million | ▲ +2509.5% |
| 2015 | 0.03x | CN¥45.02 Million | CN¥1.18 Million | ▼ -89.8% |
| 2014 | 0.26x | CN¥16.47 Million | CN¥4.24 Million | ▼ -40.7% |
| 2013 | 0.43x | CN¥6.30 Million | CN¥2.73 Million | ▼ -23.1% |
| 2012 | 0.56x | CN¥1.03 Million | CN¥582.99K | — |